VTYX News and Press, Ventyx Biosciences Inc. From 01/11/24

2024-01-11 16:37:35 ET Gainers: Ventyx Biosciences ( VTYX ) +6% . EyePoint Pharmaceuticals ( EYPT ) +3% . HashiCorp ( HCP ) +3% . Nubia Brand International  ( NUBI ) +2% . Microvision ( MVIS ) +2% . Losers: Spectaire...

NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX ). The investigation concerns whether Ventyx and/or certain of its offic...

2023-12-29 15:00:18 ET More on the markets Sentiment Speaks: The Fed Is Going To Put A Big Hurt On Everyone In 2024 5 Big Market Predictions For 2024 2024 Analyst Outlook: Lawrence Fuller On An Economic Soft Landing Scenario A Peak In Excess Liquidity May Mea...

2023-12-15 15:10:23 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week, or the Seeking Alpha earnings calendar ...

2023-12-08 15:00:12 ET More on the markets S&P 500: New All-Time Highs Before A Major Sell-Off S&P 500 Forecast 2024: Muddling Through Only Thing That Matters Is Price; Nasdaq Has Further To Go - Cestrian Capital Research Money market funds attract mo...

2023-12-07 18:18:59 ET More on Ventyx Biosciences Ventyx Biosciences Now Has 2 Strikes Oppenheimer downgrades Ventyx to perform, removes price target Seeking Alpha’s Quant Rating on Ventyx Biosciences For further details see: Ventyx Biosciences cut...

2023-12-01 15:00:02 ET More on the markets My Current View Of The S&P 500 Index: December 2023 Edition SPY: Powell's Friday Speech To Likely 'Kill' The Rally 2024 Outlook: Recession AND New All-Time Highs Bond proxies and quality stocks are expected to do...

SAN DIEGO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announ...

2023-11-18 10:30:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...

NEW YORK, NY / ACCESSWIRE / November 15, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ventyx Biosciences, Inc. ("Ventyx" or "the Company") (NASDAQ:VTYX). Investors who purchased Ventyx securities are encouraged to obtain additional in...